RGI
Roto-Gro International Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Roto-Gro International Ltd. manufactures and sells hydroponically-based rotational growing systems. The company is headquartered in Sydney, New South Wales. The company went IPO on 2017-02-10. The company is focused on providing cultivation solutions, such as automated rotary hydroponic garden system. The firm is engaged in production and sale of patented Rotational Garden Systems (the RotoGro Garden Systems) and the sale and production of automated nutrient delivery and water management systems (the Fertigation Systems). Its geographical segment includes Australia, United States and Canada. The company uses automated agricultural cultivation technology to provide solutions to the indoor vertical farming market. Its global operations are focused on supplying its technology to indoor vertical farming space for both perishable food and lawful cannabis. Its Rotational Garden Systems are supported by its enterprise edition iGrow software, nutrient management system, automation technologies, and in-house design and engineering services. The company has collaborated with Verity Greens Inc. for cultivation of perishable food.
📈 Performance
Price History
-94.50%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.22
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in RGI
2
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in RGI
523 days
RGI investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50%
50k - 100k
50%
Less than 50k
👶 Age of investors
18 - 25
26 - 34
50%
35 - 90
50%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in RGI also invest in...
Cann Group Ltd. operates research and development and cultivation facilities to grow medicinal cannabis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The firm supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. The company also owns Satipharm and its patent-protected capsule technology. The firm's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.
📊 Share price
$0.17 AUD
Incannex Healthcare Ltd. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2007-05-23. The firm is engaged in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. The firm targets five indications: obstructive sleep apnea (OSA), traumatic brain injury and concussion (TBI), rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and inflammatory lung conditions. Its drug candidates include IHL-42X, IHL-216A, Psilocybin-assisted psychotherapy for general anxiety disorder (Psi-GAD) and IHL-675A. Its IHL-42X is a cannabinoid combination product for treatment of OSA. Its IHL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. IHL-216A is a cannabinoid combination product for the treatment of TBI. The company is investigating the use of psilocybin-assisted psychotherapy to treat GAD.
📊 Share price
$0.12 AUD
Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-20. The firm has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The firm focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.
📊 Share price
$0.17 AUD
VHY.AX was created on 2011-05-26 by Vanguard. The fund's investment portfolio concentrates primarily on high dividend yield equity. Vanguard Australian Shares High Yield ETF seeks to track the return of the FTSE Australia High Dividend Yield Index before taking into account fees, expenses and tax.
📊 Share price
$66.86 AUD
NULL AUSTRALIA
NULL BETA
NULL INCOME
T3D
333D Ltd. engages in the commercialisation of 3D printing capabilities. The company is headquartered in Victor Harbor, South Australia. The company went IPO on 2006-12-27. The firm is engaged in digital and manufacturing technology to make 3D printed licensed merchandise for sports and entertainment organizations in Australia and across the world. The company provides industry-grade 3D printing. The company creates 3D printing based on the designs provided by the customers. The company offers computer-aided design (CAD), prototype, or mass production. Through Mini League it provides precision 3D printed replicas of sports stars. Bespoke 3D Printing offers 3D printing and design services.
📊 Share price
$0.00 AUD
Want more shares? Try these...
Regal Asian Investments Ltd is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-11-13. Regal Asian Investments Limited is an Australia-based company, which is engaged in investment activities. The firm provides shareholders with access to a concentrated portfolio, predominately comprised of long investments and short positions in listed securities focusing on the Asian region. The company provides investors with access to an actively managed, concentrated portfolio, comprising long investments and short positions in Asian listed securities. The company may also take positions in other companies with significant exposure to the Asian market. The firm will typically invest in 15 to 30 long investments. The Company’s portfolio is actively managed by Regal Funds Management Pty Limited.
📊 Share price
$2.00 AUD
RGB.AX was created on 2012-03-08 by Russell. The fund's investment portfolio concentrates primarily on broad credit fixed income. To aim to provide a total return before costs and tax, in line with the DBIQ 5-10 year Australian Government Bond Index over the long term.
📊 Share price